Roger A. Levy

11.4k total citations · 1 hit paper
145 papers, 5.6k citations indexed

About

Roger A. Levy is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, Roger A. Levy has authored 145 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 95 papers in Rheumatology, 40 papers in Immunology and 29 papers in Hematology. Recurrent topics in Roger A. Levy's work include Systemic Lupus Erythematosus Research (89 papers), Monoclonal and Polyclonal Antibodies Research (24 papers) and Platelet Disorders and Treatments (15 papers). Roger A. Levy is often cited by papers focused on Systemic Lupus Erythematosus Research (89 papers), Monoclonal and Polyclonal Antibodies Research (24 papers) and Platelet Disorders and Treatments (15 papers). Roger A. Levy collaborates with scholars based in Brazil, United States and United Kingdom. Roger A. Levy's co-authors include Michelle Petri, Ricard Cervera, Z. John Zhong, William W. Freimuth, Sandra Navarra, Mathew Thomas, Stephen Hall, C Tănăsescu, A Gallacher and Е. Л. Насонов and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Roger A. Levy

133 papers receiving 5.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

2011 1.4k citations A Gallacher, Stephen Hall et al. profile →

Peers

Countries citing papers authored by Roger A. Levy

Since Specialization

Citations

This map shows the geographic impact of Roger A. Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger A. Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger A. Levy more than expected).

Fields of papers citing papers by Roger A. Levy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger A. Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger A. Levy. The network helps show where Roger A. Levy may publish in the future.

Co-authorship network of co-authors of Roger A. Levy

This figure shows the co-authorship network connecting the top 25 collaborators of Roger A. Levy. A scholar is included among the top collaborators of Roger A. Levy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger A. Levy. Roger A. Levy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The effect of belimumab on mucocutaneous and vasculitis manifestations in patients with systemic lupus erythematosus: A large pooled post hoc analysis 2025 ·Lupus ·Susan Manzi, Jorge Sánchez‐Guerrero, Naoto Yokogawa, Joerg Wenzel, (unknown), Julia Harris, Munther A. Khamashta, Bernard Rubin, Norma Lynn Fox, Roger A. Levy, Victoria P. Werth	0
2	Clinical and economic burden of organ damage among patients with systemic lupus erythematosus in a real-world setting in Germany 2024 ·BMC Rheumatology ·(unknown), (unknown), (unknown), Roger A. Levy, (unknown), Matthias Schneider, Kerry Gairy	1
3	AB0531 APPLYING THE WORKING DEFINITION OF THE DISEASE MODIFICATION CRITERIA TO LUPUS NEPHRITIS TREATMENTS FROM THE PUBLISHED LITERATURE 2023 ·Annals of the Rheumatic Diseases ·(unknown), Richard Furie, Maria Dall’Era, Andrew S. Bomback, Andreas Schwarting, Ming‐Hui Zhao, Ian N Bruce, Munther A. Khamashta, Bernard Rubin, (unknown), Maxine Daniels, Roger A. Levy, Ronald van Vollenhoven, Murray B. Urowitz	1
4	Belimumab versus anifrolumab in adults with systemic lupus erythematosus: an indirect comparison of clinical response at 52 weeks 2023 ·Lupus Science & Medicine ·Binod Neupane, (unknown), Mahmoud Slim, Amber Martin, Michelle Petri, George Βertsias, Alfred H.J. Kim, Antonis Fanouriakis, Roger A. Levy, (unknown), Nick Ballew	9
5	Lupus spectrum ambiguity has long-term negative implications for patients 2023 ·Lupus Science & Medicine ·Ian N Bruce, Joy Buie, (unknown), Sang‐Cheol Bae, Karen H. Costenbader, Roger A. Levy, Victoria P. Werth, (unknown), (unknown), Susan Manzi	11
6	Identifying Barriers to Enrollment in Patient Pregnancy Registries: Building Evidence Through Crowdsourcing 2022 ·JMIR Formative Research ·Jeanne M. Pimenta, Jeffery L. Painter, (unknown), Roger A. Levy, Marcy Powell, (unknown), (unknown)	0
7	Conceptual framework for defining disease modification in systemic lupus erythematosus: a call for formal criteria 2022 ·Lupus Science & Medicine ·Ronald van Vollenhoven, Anca Askanase, Andrew S. Bomback, Ian N Bruce, (unknown), Maria Dall’Era, (unknown), Roger A. Levy, Andreas Schwarting, (unknown), Murray B. Urowitz, Ming‐Hui Zhao, Richard Furie	31
8	Premature rupture of membranes – A cause of foetal complications among lupus: A cohort study, systematic review and meta-analysis 2021 ·Lupus ·Flávia Cunha dos Santos, (unknown), (unknown), Luís Guillermo Coca Velarde, Roger A. Levy, Guilherme Ramires de Jesús, Nilson Ramires de Jesús, Carlos Augusto Ferreira de Andrade, Evandro Mendes Klumb	5
9	Pulmonary hypertension in systemic sclerosis: diagnosis by systematic screening and prognosis after three years follow-up 2021 ·BMC Pulmonary Medicine ·Verônica Silva Vilela, (unknown), (unknown), (unknown), Agnaldo José Lopes, (unknown), (unknown), Cláudia Henrique da Costa, Roger A. Levy, Rogério Rufino	3
10	Improvements in health-related quality of life with belimumab, a B-lymphocyte stimulator-specific inhibitor, in patients with autoantibody-positive systemic lupus erythematosus from the randomised controlled BLISS trials 2013 ·Annals of the Rheumatic Diseases ·Vibeke Strand, Roger A. Levy, Ricard Cervera, Michelle Petri, Helen L. Birch, William W. Freimuth, Z. John Zhong, Ann E. Clarke	113
11	Late‐breaking abstracts: American College of Rheumatology 2009 Annual Scientific Meeting 2009 ·Arthritis & Rheumatism ·(unknown), A Gallacher, Roger A. Levy, (unknown), Mathew Thomas, Roland Jimenez, M.B. Leon, Stephen Hall, Joung‐Liang Lan, Е. Л. Насонов, C Tănăsescu, (unknown), (unknown), (unknown), William W. Freimuth, Michelle Petri, (unknown), (unknown)	4
12	Management of Patients With Rheumatoid Arthritis in Latin America 2009 ·JCR Journal of Clinical Rheumatology ·Loreto Massardo, María E. Suarez‐Almazor, Mario H. Cardiel, Arnulfo Nava, Roger A. Levy, Iêda Maria Magalhães Laurindo, Enrique R. Soriano, Eduardo M. Acevedo‐Vásquez, (unknown), Carlos Pineda, Claudio Galarza-Maldonado, Carlo V. Caballero‐Uribe, (unknown), Bernardo A. Pons‐Estel	35
13	Amputation of Digits or Limbs in Patients with Antiphospholipid Syndrome 2008 ·Seminars in Arthritis and Rheumatism ·Ronald A. Asherson, Ricard Cervera, Evandro Mendes Klumb, (unknown), Piercarlo Sarzi‐Puttini, (unknown), Silvia Bucciarelli, Gerard Espinosa, Roger A. Levy, Yehuda Shoenfeld	28
14	Antiphospholipid Syndrome and Cognition 2007 ·Clinical Reviews in Allergy & Immunology ·Bernardo Liberato, Roger A. Levy	6
15	An adapted ELISA method for differentiating pathogenic from nonpathogenic aPL by a beta 2 glycoprotein I dependency anticardiolipin assay 2004 ·Thrombosis Research ·Roger A. Levy, Ernesto de Meis, Silvia S. Pierangeli	23
16	Anticoagulação durante a gestação 2002 ·Revista Brasileira de Reumatologia ·Verônica Silva Vilela, (unknown), Roger A. Levy	1
17	Catastrophic Antiphospholipid Syndrome: Clinical and Laboratory Features of 50 Patients 1998 ·Medicine ·Ronald A. Asherson, Ricard Cervera, Jean‐Charles Piette, Josep Font, J. T. Lie, (unknown), (unknown), Francisco J. Muñoz, Roger A. Levy, François Boué, Jérôme Rossert, M Ingelmo	369
18	Esclerodermia sistemica e gravidez - Relato de caso 1997 ·(unknown), (unknown), Roger A. Levy, (unknown)	0
19	Histologia placentária nas gestaçoes de alto risco: lúpus eritematoso sistêmico e pré-eclâmpsia 1996 ·(unknown), Roger A. Levy, (unknown), Luís Cristóvão Pôrto	1
20	[Development and long term prognosis of lupus erythematosus (apropos of 124 cases)]. 1977 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·P Godeau, (unknown), Piette Jc, G Herreman, B Wechsler, Roger A. Levy	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact